Inside the White House with D.C.'s most wired reporter. Sign up for Mike Allen's Axios AM.

Stories

What to watch in Trump's drug pricing speech

President Trump and HHS Secretary Alex Azar. Photo: Nicholas Kamm/AFP/Getty Images

President Trump is headed to the Department of Health and Human Services this afternoon for a speech on drug prices with HHS Secretary Alex Azar.

What we're watching: Expect a heavy emphasis on Medicare Part B — the part that pays for drugs administered in a doctor's office.

  • Flashback: One of the more ambitious proposals in Trump and Azar's drug-pricing blueprint calls for shifting some drugs from Medicare Part B, which pays fixed prices, into Medicare Part D, where private companies negotiate discounts.

Driving the news: Medicare pays almost twice as much as other industrialized countries for many of the most expensive prescription drugs, according to a new report HHS released this morning that's focused on Part B drugs.

Details: HHS looked at the prices for 27 drugs, comparing them to the prices in 16 similar countries, mostly in Europe. Together, those 27 products make up about 60% of all spending in Part B.

  • The U.S. had the highest price for 19 of those 27 drugs.
  • HHS only found 1 drug whose U.S. price was lower than its average international price. Among the other 26, the U.S. prices were as much as 7 times higher.
  • Medicare pays an average of 1.8 times more than those other countries for these drugs.

Go deeper:

More stories loading.